Back to search

University of Birmingham

Validation and identification of tumour endothelial markers and their uses in cancer vaccine

Abstract

dc:description.abstract

The abnormal tumour microenvironment, which is typically hypoxic, acidic and with poor blood flow, induces the endothelial expression of genes not found on normal microvessels. By selectively targeting these tumour endothelial markers (TEMs) it is possible to induce tumour regression, presenting a potential strategy for therapeutic intervention. Potential TEMs were predicted by bioinformatics data mining. Validation of these TEM candidates identified a novel TEM CLEC14A. Functional characterization suggests a regulatory role of CLEC14A in endothelial cell migration. Inhibition of endothelial migration by CLEC14A antisera or monoclonal antibody holds therapeutic promise for the treatment of cancer. Differential gene expression analysis of freshly isolated lung tumour endothelium by 2nd generation sequencing identified 13 putative TEMs. Subsequent validation work confirmed six of which to be expressed on lung tumour vasculature. Finally, a pre-validated marker, Robo4, was investigated as a cancer vaccine. A strong antibody response was induced by delivery of pure mouse Robo4 protein or a Robo4 conjugate. The in vivo sponge assay in Robo4 vaccinated mice showed a significant reduction in vessel invasion. Tumour implantation experiments in vaccinated mice showed a marked delay in tumour growth.

Degree

thesis:*
Name dc:type.qualificationname
d_ph
Level dc:type.qualificationlevel
d_ph
Grantor dc:publisher.institution
University of Birmingham
Year dc:date.issued
2013

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Zhuang, Xiaodong

Subjects

dc:subject × 2

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
University of Birmingham
Base URL
etheses.bham.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Zhuang, Xiaodong. Validation and identification of tumour endothelial markers and their uses in cancer vaccine. d_ph thesis, University of Birmingham, 2013.